These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1980547)

  • 1. [Parkinsonian syndrome. Etiology, diagnosis, treatment].
    Montastruc JL
    Rev Prat; 1990 Nov; 40(27):2555-9. PubMed ID: 1980547
    [No Abstract]   [Full Text] [Related]  

  • 2. [Progress in therapy of Parkinsonian syndrome].
    Völler GW
    Hippokrates; 1975 Feb; 46(1):17-33. PubMed ID: 1091605
    [No Abstract]   [Full Text] [Related]  

  • 3. [The apomorphine test for diagnosis of parkinsonian syndrome].
    Piccini P; Del Dotto P; Napolitano A; Pardini C; Bonuccelli U
    Riv Neurol; 1990; 60(6):221-3. PubMed ID: 2100046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of Parkinson's syndrome using a new preparation from the series of tricyclic psychotropic drugs].
    Deze J; Völler GW
    Med Welt; 1975 Aug; 26(33-34):1457-62. PubMed ID: 1100988
    [No Abstract]   [Full Text] [Related]  

  • 5. [Parkinson syndrome, frontal tumor and L-dopa].
    Lhermitte F; Agid Y; Serdaru M; Guimaraes J
    Rev Neurol (Paris); 1984; 140(2):138-9. PubMed ID: 6710014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Generating mechanism and treatment of parkinsonian symptoms].
    Narabayashi H
    Rinsho Shinkeigaku; 1982 Dec; 22(12):1055-62. PubMed ID: 7168940
    [No Abstract]   [Full Text] [Related]  

  • 7. [Trial use of L-dopa associated with a dopa-decarboxylase inhibitor in Parkinson's syndrome].
    Carotti A; Tomassetti G; Lucciarini L; Barone G; Mugnai A
    Clin Ter; 1974 Jul; 70(1):9-15. PubMed ID: 4153252
    [No Abstract]   [Full Text] [Related]  

  • 8. Parkinsonian manifestations in a patient with homocystinuria.
    Keskin S; Yurdakul F
    J Child Neurol; 1996 May; 11(3):235-6. PubMed ID: 8734028
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of liposomal form of L-Dopa on the development of parkinsonian syndrome in mice].
    Kucherianu VG; Iurasov VV; Kryzhanovskiĭ GN; Nikushkin EV; Zhigal'tsev IV; Kaplun VP; Shvets VI
    Biull Eksp Biol Med; 1997 Jan; 123(1):29-33. PubMed ID: 9213451
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current treatment of Parkinsonian syndrome].
    Lechner H; Bertha G; Ott E
    Med Welt; 1980 Oct; 31(40):1444-6. PubMed ID: 7464500
    [No Abstract]   [Full Text] [Related]  

  • 11. Drugs for Parkinson's disease.
    Med Lett Drugs Ther; 1993 Apr; 35(894):31-4. PubMed ID: 8096322
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antiparkinsonian drugs].
    Rascol A; Montastruc JL; Rascol O
    Rev Prat; 1989 Mar; 39(8):663-9. PubMed ID: 2567051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional MRI of basal ganglia responsiveness to levodopa in parkinsonian rhesus monkeys.
    Chen Q; Andersen AH; Zhang Z; Ovadia A; Cass WA; Gash DM; Avison MJ
    Exp Neurol; 1999 Jul; 158(1):63-75. PubMed ID: 10448418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of the probenecid test in the diagnosis and treatment of parkinson disease].
    Vanderheyden JE; Noel G; Mendlewicz J
    Acta Neurol Belg; 1982; 82(6):339-52. PubMed ID: 7164768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levodopa treatment of Parkinson's syndrome: past and future.
    Pletscher A
    Adv Neurol; 1990; 53():469-73. PubMed ID: 2239486
    [No Abstract]   [Full Text] [Related]  

  • 16. Nosological concept of juvenile parkinsonism with reference to the dopa-responsive syndrome.
    Yokochi M
    Adv Neurol; 1993; 60():548-52. PubMed ID: 8420189
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cognition disorders and parkinsonian syndrome: diffuse Lewy body disease?].
    Etcharry-Bouyx F; Gambarelli D; Kassis N; Gosset A; Bonnefoi-Kyriacou B; Viallet F
    Rev Neurol (Paris); 1995; 151(6-7):410-2. PubMed ID: 7481406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of levodopa treatment for parkinsonism in welders: a double-blind study.
    Chu NS
    Neurology; 2004 Oct; 63(8):1541; author reply 1541. PubMed ID: 15505194
    [No Abstract]   [Full Text] [Related]  

  • 19. Vascular parkinsonism--an important update.
    Turnbull C
    Age Ageing; 2005 Mar; 34(2):97-8. PubMed ID: 15713851
    [No Abstract]   [Full Text] [Related]  

  • 20. Movement disorders with neuroleptic drug treatment.
    Tarsy D
    Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.